1-8 of 8
David M. Kofler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Phase Ib Trial of Atacicept to Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia (CLL).

David M Kofler, MD, Barbara B Gawlik, MD, Thomas Elter, MD, Athos Gianella-Borradori, MD, Clemens M Wendtner, MD, Michael Hallek, MD
Journal: Blood
Blood (2009) 114 (22): 2373.
https://doi.org/10.1182/blood.V114.22.2373.2373
Published: 2009
Journal Articles

CD28 Costimulation of Effector T Cells During An Anti-Tumor Attack Sustains Its Repression by Regulatory T Cells Which Can Be Overcome by Preventing Lck Activation.

David M Kofler, MD, Markus Chmielewski, PhD, Tobias Riet, Andreas Hombach, MD, Michael Hallek, MD, Clemens M Wendtner, MD, Hinrich Abken, MD
Journal: Blood
Blood (2009) 114 (22): 3569.
https://doi.org/10.1182/blood.V114.22.3569.3569
Published: 2009
Journal Articles

Impact of Regulatory T Cells on Antigen Specific T Cell Response Using Recombinant Chimeric T Cell Receptors In Vivo.

David M. Kofler, MD, Markus Chmielewski, Heike Koehler, Tobias Riet, Patrick Schmidt, Gunter Rappl, Andreas Hombach, MD, Michael Hallek, MD, Clemens M. Wendtner, MD, Hinrich Abken, MD
Journal: Blood
Blood (2006) 108 (11): 5475.
https://doi.org/10.1182/blood.V108.11.5475.5475
Published: 2006
Journal Articles

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia

Clinical Trials & Observations
Christine Mayr, Michael R. Speicher, David M. Kofler, Raymund Buhmann, John Strehl, Raymonde Busch, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2006) 107 (2): 742–751.
https://doi.org/10.1182/blood-2005-05-2093
Published: 2006
Journal Articles

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Brief Report
Christine Mayr, David M. Kofler, Hildegard Büning, Dagmar Bund, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 106 (9): 3223–3226.
https://doi.org/10.1182/blood-2005-04-1742
Published: 2005
Journal Articles

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Christine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M. Kofler, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 105 (4): 1566–1573.
https://doi.org/10.1182/blood-2004-04-1233
Published: 2005
Journal Articles

High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome.

Christine Mayr, MD, David M. Kofler, MD, Raymund Buhmann, MD, John Strehl, MD, Raymonde Busch, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 17.
https://doi.org/10.1182/blood.V104.11.17.17
Published: 2004
Journal Articles

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors

Clemens-Martin Wendtner, David M. Kofler, Hans D. Theiss, Christian Kurzeder, Raymund Buhmann, Carmen Schweighofer, Luca Perabo, Susanne Danhauser-Riedl, Jens Baumert, Wolfgang Hiddemann, Michael Hallek, Hildegard Büning
Journal: Blood
Blood (2002) 100 (5): 1655–1661.
https://doi.org/10.1182/blood.V100.5.1655.h81702001655_1655_1661
Published: 2002